Edition:
United States

MEDNAX Inc (MD.N)

MD.N on New York Stock Exchange

45.60USD
21 Sep 2018
Change (% chg)

$-1.93 (-4.06%)
Prev Close
$47.53
Open
$47.54
Day's High
$47.61
Day's Low
$45.38
Volume
712,076
Avg. Vol
223,189
52-wk High
$62.75
52-wk Low
$40.56

Latest Key Developments (Source: Significant Developments)

MEDNAX Announces Acquisition Of Pediatric Urology Practice In South Florida
Monday, 2 Apr 2018 06:45am EDT 

April 2 (Reuters) - MEDNAX Inc ::MEDNAX ANNOUNCES ACQUISITION OF PEDIATRIC UROLOGY PRACTICE IN SOUTH FLORIDA.‍NO ADDITIONAL TERMS OF TRANSACTION WERE DISCLOSED.​.‍DEAL WAS A CASH TRANSACTION AND IT IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO EARNINGS​.WITH ACQUISITION, FOUR PHYSICIAN GROUP PRACTICES HAVE BECOME PART OF MEDNAX IN 2018.  Full Article

Mednax Says CEO Roger Medel's Total Compensation For 2017 Was $7.4 Mln Versus $7.8 Mln In 2016
Friday, 23 Mar 2018 04:49pm EDT 

March 23 (Reuters) - Mednax Inc ::MEDNAX INC SAYS CEO ROGER J. MEDEL'S TOTAL COMPENSATION FOR 2017 WAS $7.4 MILLION VERSUS $7.8 MILLION IN 2016 - SEC FILING‍​.  Full Article

Mednax Announces Acquisition Of Pediatric Ophthalmology Practice In Washington
Wednesday, 21 Mar 2018 06:45am EDT 

March 21 (Reuters) - Mednax Inc ::MEDNAX ANNOUNCES ACQUISITION OF PEDIATRIC OPHTHALMOLOGY PRACTICE IN WASHINGTON.MEDNAX INC - ‍NO ADDITIONAL TERMS OF TRANSACTION WERE DISCLOSED.​.MEDNAX INC - ‍NO ADDITIONAL TERMS OF TRANSACTION WERE DISCLOSED.​.MEDNAX INC - DEAL WAS A CASH TRANSACTION AND IT IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO EARNINGS​.MEDNAX INC - ‍ANNOUNCED ACQUISITION OF CHILDREN'S EYE CARE, LLC, A PRIVATE PEDIATRIC OPHTHALMOLOGY PRACTICE.  Full Article

Mednax Reports Q4 Adjusted Earnings Per Share Of $0.87
Thursday, 8 Feb 2018 06:00am EST 

Feb 8 (Reuters) - Mednax Inc ::MEDNAX REPORTS FOURTH QUARTER GAAP EPS OF $1.46.SEES Q1 2018 ADJUSTED EARNINGS PER SHARE $0.84 TO $0.89.SEES Q1 2018 EARNINGS PER SHARE $0.63 TO $0.68.Q4 ADJUSTED EARNINGS PER SHARE $0.87.Q4 EARNINGS PER SHARE $1.46.Q4 REVENUE $911 MILLION.Q4 SAME STORE SALES ROSE 3.9 PERCENT.Q4 EARNINGS PER SHARE VIEW $0.83, REVENUE VIEW $885.1 MILLION -- THOMSON REUTERS I/B/E/S.Q1 EARNINGS PER SHARE VIEW $0.78, REVENUE VIEW $889.9 MILLION -- THOMSON REUTERS I/B/E/S.QTRLY RESULTS INCLUDE $0.75 PER SHARE OF INCOME TAX BENEFIT RELATED TO IMPACTS FROM TAX CUTS AND JOBS ACT OF 2017.Q1 2018 OUTLOOK ASSUMES THAT TOTAL SAME-UNIT REVENUE GROWTH FOR 3 MONTHS ENDED MARCH 31 WILL BE IN A RANGE OF TWO TO FOUR PERCENT.FOR Q1 2018, CO EXPECTS EBITDA GROWTH WILL BE BETWEEN NEGATIVE FOUR PERCENT AND POSITIVE ONE PERCENT.  Full Article

Mednax Announces Acquisition Of Neonatology Practice In California
Wednesday, 10 Jan 2018 06:45am EST 

Jan 10 (Reuters) - Mednax Inc ::MEDNAX INC - ‍NO ADDITIONAL TERMS OF TRANSACTION WERE DISCLOSED​.MEDNAX - DEAL WAS CASH TRANSACTION AND IT IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO EARNINGS.MEDNAX ANNOUNCES ACQUISITION OF NEONATOLOGY PRACTICE IN CALIFORNIA.  Full Article

Elliott, Elliott International & EICA collectively combines economic exposure in MEDNAX
Thursday, 16 Nov 2017 09:28am EST 

Nov 16 (Reuters) - MEDNAX Inc :Elliott says Elliott, Elliott International & EICA collectively have combined economic exposure in MEDNAX of about 7.0% of stock as of Nov 6.‍Elliott​ Managemenet- believe MEDNAX Securities undervalued; seek to engage with MEDNAX management,board on strategic options,operational opportunities.‍Elliott​ Managemenet- may propose potential changes in operations, management, board, potential strategic transactions involving mednax, some assets, among others.Elliott​ Management says intends to talk with MEDNAX's management about operational matters, including sale of MEDNAX or some of its businesses.  Full Article

Mednax reports Q3 earnings per share of $0.71
Wednesday, 1 Nov 2017 06:00am EDT 

Nov 1 (Reuters) - Mednax Inc :Mednax reports third quarter GAAP EPS of $0.71; adjusted EPS of $0.87.Sees Q4 2017 adjusted earnings per share $0.80 to $0.85.Sees Q4 2017 earnings per share $0.64 to $0.69.Q3 earnings per share $0.71.Q3 adjusted earnings per share $0.87.Q3 revenue $869 million versus I/B/E/S view $866.4 million.Q3 same store sales rose 0.7 percent.Q3 earnings per share view $0.85 -- Thomson Reuters I/B/E/S.Mednax Inc - estimates that hurricane impact reduced net revenue during quarter by approximately $2 million and adjusted EPS by approximately $0.01​.Mednax - ‍Q4 outlook assumes total same-unit revenue growth for 3 months ended December 31, 2017 to be in a range of flat to 2 percent versus prior-year period​.Mednax Inc - ‍outlook assumes that total same-unit revenue growth for three months ended December 31, 2017 will be in a range of flat to 2 percent​.  Full Article

MEDNAX ACQUIRES RADIOLOGY PHYSICIAN GROUP SYNERGY RADIOLOGY ASSOCIATES
Wednesday, 18 Oct 2017 06:45am EDT 

Oct 18 (Reuters) - MEDNAX Inc ::MEDNAX ANNOUNCES ACQUISITION OF LEADING TEXAS RADIOLOGY PRACTICE.MEDNAX INC - ‍NO ADDITIONAL TERMS OF TRANSACTION WERE DISCLOSED.​.MEDNAX INC - DEAL WAS A CASH AND EQUITY TRANSACTION AND IT IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO EARNINGS​.MEDNAX INC - ‍ACQUISITION OF SYNERGY RADIOLOGY ASSOCIATES, PA.MEDNAX INC - ‍WITH ACQUISITION, 10 PHYSICIAN GROUP PRACTICES HAVE BECOME PART OF MEDNAX IN 2017.  Full Article

Mednax acquires pediatric urology practice in South Florida
Monday, 2 Oct 2017 06:45am EDT 

Oct 2 (Reuters) - Mednax Inc :Mednax announces acquisition of pediatric urology practice in south florida.Mednax Inc - ‍this was a cash transaction and it is expected to be immediately accretive to earnings​.Mednax Inc - ‍no additional terms of transaction were disclosed​.  Full Article

Mednax announces acquisition of South Florida radiology practice
Wednesday, 23 Aug 2017 06:45am EDT 

Aug 23 (Reuters) - Mednax Inc :Mednax announces acquisition of leading South Florida radiology practice.Mednax Inc- ‍No additional terms of transaction were disclosed​.Mednax Inc - ‍Upon completion of transaction, Mednax's radiology group will read more than eight million studies annually​.Mednax Inc - Deal was a cash transaction and it is expected to be immediately accretive to earnings​.  Full Article

Chanos shorts Envision, says KKR may get cold feet on deal

NEW YORK Hedge fund manager Jim Chanos says he is betting that the stocks of physican practice management companies Mednax and Envision Healthcare will fall and said that private equity group KKR might get cold feet on a planned deal for Envision.